Whole-Genome Liability | GenomeWeb

As whole-genome sequencing becomes more common in the clinic, doctors may be facing the consequences of the technological shift, says this article at Slate from Future Tense's Gary Marchant and Rachel Lindor. Whole-genome sequencing opens up a number of liabilities for physicians, Marchant and Lindor say.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Breaching the Barrier

Da Vinci's Code

Some Coverage

This Week in Nature

This Week in PLOS

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.